Clinical trial
A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression
NCT02011815 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 10, 2013
- Completion date
- June 15, 2019
- Enrollment
- 236 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.